Kidney transplant candidate evaluation

Seminars in Dialysis

Volumn 18, Issue 6, 2005, Pages 487-494

  Scandling, John D ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; COMORBIDITY; HEALTH EDUCATION; HOSPITAL ADMISSION; HUMAN; KIDNEY TRANSPLANTATION; MOTIVATION; PATIENT REFERRAL; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; RESOURCE ALLOCATION; REVIEW;

COMORBIDITY; HEALTH EDUCATION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MOTIVATION; PATIENT SELECTION; REFERRAL AND CONSULTATION; RESOURCE ALLOCATION; WAITING LISTS;

EID: 30744438571     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2005.00094.x     Document Type: Review

References (45)

1. European Best Practice Guidelines for Renal Transplantation (part 1). Nephrol Dial Transplant 15(suppl 7):1-85, 2000
2. Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D, Rush DN, Vazquez MA, Weir MR: The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant 1(suppl 2):3-95, 2001
3. Ramos EL, Kasiske BL, Alexander SR, Danovitch GM, Harmon WE, Kahana L, Kiresuk TJ, Neylan JF: The evaluation of candidates for renal transplantation. The current practice of U.S. transplant centers. Transplantation 57:490-497, 1994
4. U.S. Renal Data System: USRDS 2004 annual data report. Am J Kidney Dis 45:8-280, 2005
5. Danovitch GM, Cohen DJ, Weir MR, Stock PG, Bennett WM, Christensen LL, Sung RS: Current status of kidney and pancreas transplantation in the United States, 1994-2003. Am J Transplant 5:904-915, 2005
6. Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A, Chen SC, King K, Klag MJ, Molony DA, Flack JM: Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 42:22-35, 2003
7. Winkelmayer WC, Glynn RJ, Levin R, Mittleman MA, Pliskin JS, Avorn J: Late nephrologist referral and access to renal transplantation. Transplantation 73:1918-1923, 2002
8. Weng FL, Mange KC: A comparison of persons who present for preemptive and nonpreemptive kidney transplantation. Am J Kidney Dis 42:1050-1057, 2003
9. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725-1730, 1999
10. Leung N, Lager DJ, Gertz MA, Wilson K, Kanakiriya S, Fervenza FC: Long-term outcome of renal transplantation in light-chain deposition disease. Am J Kidney Dis 43:147-153, 2004
11. Loirat C, Niaudet P: The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr Nephrol 18:1095-1101, 2003
12. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296-1305, 2004
13. Kiberd B, Keough-Ryan T, Panek R: Cardiovascular disease reduction in the outpatient kidney transplant clinic. Am J Transplant 3:1393-1399, 2003
14. Manske CL, Thomas W, Wang Y, Wilson RF: Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 44:617-621, 1993
15. Le A, Wilson R, Douek K, Pulliam L, Tolzman D, Norman D, Barry J, Bennett W: Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis 24:65-71, 1994
16. Fishbane S: Cardiovascular risk evaluation before kidney transplantation. J Am Soc Nephrol 16:843-845, 2005
17. Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ: Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol 14:431-439, 2003
18. De Lima JJ, Sabbaga E, Vieira ML, de Paula FJ, Ianhez LE, Krieger EM, Ramires JA: Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension 42:263-268, 2003
19. Manske CL, Wang Y, Rector T, Wilson RF, White CW: Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 340:998-1002, 1992
20. Gaston RS, Basadonna G, Cosio FG, Davis CL, Kasiske BL, Larsen J, Leichtman AB, Delmonico FL: Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report. Am J Kidney Dis 44:529-542, 2004
21. Manske CL, Sprafka JM, Strony JT, Wang Y: Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89:615-620, 1990
22. Himelman RB, Landzberg JS, Simonson JS, Amend W, Bouchard A, Merz R, Schiller NB: Cardiac consequences of renal transplantation: changes in left ventricular morphology and function. J Am Coll Cardiol 12:915-923, 1988
23. Nakamura N, Arakaki Y, Sunagawa H, Shiohira Y, Uehara H, Miyasato T, Koyama Y, Ogawa Y, Kowatari T: Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transplant Proc 30:1324-1326, 1998
24. Tanabe K, Kitani R, Takahashi K, Tokumoto T, Ishikawa N, Oshima T, Kanematsu A, Fuchinoue S, Yagisawa T, Ota K, Toma H: Long-term results in human T-cell leukemia virus type 1-positive renal transplant recipients. Transplant Proc 30:3168-3170, 1998
25. Fabrizi F, Dulai G, Dixit V, Bunnapradist S, Martin P: Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials. Transplantation 77:859-864, 2004
26. Fabrizi F, Bunnapradist S, Martin P: HBV infection in patients with end-stage renal disease. Semin Liver Dis 24(suppl 1):63-70, 2004
27. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 161(4 pt 2):S221-S247, 2000
28. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C: Cancer after kidney transplantation in the United States. Am J Transplant 4:905-913, 2004
29. Kiberd BA, Keough-Ryan T, Clase CM: Screening for prostate, breast and colorectal cancer in renal transplant recipients. Am J Transplant 3:619-625, 2003
30. Danovitch GM: Guidelines on the firing-line. Am J Transplant 3:514-515, 2003
31. Weir MR, Kirkman RL, Strom TB, Tilney NL: Liver disease in recipients of long-functioning renal allografts. Kidney Int 28:839-844, 1985
32. Gane E, Pilmore H: Management of chronic viral hepatitis before and after renal transplantation. Transplantation 74:427-437, 2002
33. Israni AK, Feldman HI, Propert KJ, Leonard M, Mange KC: Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival. Am J Transplant 5:374-382, 2005
34. Friedman GS, Meier-Kriesche HU, Kaplan B, Mathis AS, Bonomini L, Shah N, DeFranco P, Jacobs M, Mulgaonkar S, Geffner S, Lyman N, Paraan C, Walsh C, Belizaire W, Tshibaka M: Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis. Transplantation 72:1073-1078, 2001
35. Nyberg G, Hallste G, Norden G, Hadimeri H, Wramner L: Physical performance does not improve in elderly patients following successful kidney transplantation. Nephrol Dial Transplant 10:86-90, 1995
36. Mange KC, Joffe MM, Feldman HI: Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 344:726-731, 2001
37. Cosio FG, Alamir A, Yim S, Pesavento TE, Falkenhain ME, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM: Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 53:767-772, 1998
38. Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, Hanson JA, Cibrik DM, Leichtman AB, Kaplan B: Effect of waiting time on renal transplant outcome. Kidney Int 58:1311-1317, 2000
39. Meier-Kriesche HU, Kaplan B: Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 74:1377-1381, 2002
40. Kasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT: Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol 13:1358-1364, 2002
41. Ishani A, Ibrahim HN, Gilbertson D, Collins AJ: The impact of residual renal function on graft and patient survival rates in recipients of preemptive renal transplants. Am J Kidney Dis 42:1275-1282, 2003
42. Danovitch GM, Hariharan S, Pirsch JD, Rush D, Roth D, Ramos E, Starling RC, Cangro C, Weir MR: Management of the waiting list for cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. J Am Soc Nephrol 13:528-535, 2002
43. Gaston RS, Danovitch GM, Adams PL, Wynn JJ, Merion RM, Deierhoi MH, Metzger RA, Cecka JM, Harmon WE, Leichtman AB, Spital A, Blumberg E, Herzog CA, Wolfe RA, Tyan DB, Roberts J, Rohrer R, Port FK, Delmonico FL: The report of a national conference on the wait list for kidney transplantation. Am J Transplant 3:775-785, 2003
44. Matas AJ, Kasiske B, Miller L: Proposed guidelines for re-evaluation of patients on the waiting list for renal cadaver transplantation. Transplantation 73:811-812, 2002
45. Danovitch GM, Cecka JM: Allocation of deceased donor kidneys: past, present, and future. Am J Kidney Dis 42:882-890, 2003